Quinovare to Attend BIO-Europe 2025 in Vienna, Austria
November 2025 – Vienna, Austria — Quinovare is pleased to announce that its leadership team will attend BIO-Europe 2025, taking place from November 3–5, 2025, in Vienna, Austria. The event serves as one of the world’s leading platforms for biopharmaceutical innovation, partnering, and collaboration.
Advancing the Future of Needle-Free Drug Delivery
At Quinovare, we are pioneering needle-free injection technologies that transform the way injectable medicines are delivered. Our innovative systems provide precise, efficient, and comfortable drug delivery, addressing unmet needs in vaccination, biologics, insulin therapy, and chronic disease management. By eliminating the need for traditional needles, our technology enhances patient compliance, reduces pain, and simplifies the injection process for healthcare providers.
During BIO-Europe, Quinovare representatives will be available for meetings through the PartneringONE® platform to discuss potential collaborations, technology licensing, and strategic partnerships with global pharmaceutical and biotech companies.
About Quinovare
Quinovare specializes in the research, development, and commercialization of needle-free injection technologies, offering innovative and patient-friendly solutions for drug delivery. With a strong focus on safety, efficiency, and user experience, Quinovare’s products are designed to support the global shift toward more accessible and advanced healthcare delivery.
Contact Information
For more information or to schedule a meeting during BIO-Europe, please contact: